An independent, evidence-based review of Hallandale Pharmacy's medical leadership, licensing credentials, compounding practices, and regulatory history. Includes FDA, state board, BBB, and LegitScript findings.
An independent review of Happy Head's LegitScript status, state pharmacy accreditation, FDA compliance, BBB rating, and patient complaints, everything you need before starting compounded hair-loss treatment.
An independent look at Happy Head's compounded hair-loss formulas, prescribing patterns, regulatory standing, and the clinical evidence behind the ingredients they use.
An independent, evidence-based review of Hers telehealth's medical leadership, physician credentials, prescribing oversight, regulatory standing, and complaint history, so you can make an informed decision before subscribing.
An independent review of Hers telehealth prescribing patterns, outcomes data, regulatory signals, and patient complaints across women's HRT, weight loss, mental health, and hair treatments.
An independent, evidence-based review of Hims telehealth prescribing patterns, outcomes data, FDA and BBB records, and complaint signals for men's HRT, ED, hair loss, and mental health.
An independent look at InsideTracker's BBB rating, verified consumer complaints, regulatory standing, and what those trends mean before you subscribe.
An independent assessment of InsideTracker's LegitScript status, BBB rating, regulatory standing, and what accreditation gaps mean for consumers buying blood-based health optimization services.
An independent, evidence-based review of InsideTracker's medical leadership, scientific credentials, advisory board, regulatory standing, and complaint history. Board-reviewed by HealthRX.com physicians.
An independent review of Juniper's BBB profile, consumer complaints, regulatory standing, and telehealth legitimacy for women seeking GLP-1 weight-loss treatment.
An independent clinical review of Juniper's GLP-1 telehealth program for women, including specific patient profiles that should avoid it, safety data, and regulatory standing.
An independent review of Keeps' LegitScript certification, state pharmacy board compliance, BBB rating, FDA drug approvals, and patient complaint history for men's hair loss treatment.
An independent review of Levels Health CGM subscription data, prescribing practices, complaints, and outcomes signals. Includes primary-source citations and a critical look at whether Levels is legit.
An independent, evidence-based look at Life Extension's BBB rating, verified consumer complaints, FDA warning history, and how the brand compares to regulatory benchmarks for longevity supplements.
An independent review of Life Extension's LegitScript status, BBB rating, FDA warning letters, state pharmacy board standing, and supplement quality credentials. Updated with current primary-source data.
An independent, evidence-based review of Life Extension's medical leadership, scientific credentials, regulatory history, and legitimacy as a supplement and longevity brand.
A data-driven review of Life Extension supplement and Rx pricing history, price trajectory, legitimacy, and consumer complaints. prepared by the HealthRX.com Editorial Team.
A guide to the specific patient profiles who should avoid Life Extension supplements and prescription offerings, including drug interactions, contraindications, and red flags for vulnerable groups.
An independent review of Limitless Life complaints filed with the BBB, state pharmacy boards, and federal agencies. We examine what patterns exist, what regulators have said, and what prospective patients should check before ordering peptides or NAD+ online.
An evidence-based, critical review of Limitless Life's medical leadership, physician oversight, compounding practices, and legitimacy. Includes FDA, state board, and LegitScript analysis.
An independent, evidence-based review of Marek Health's LegitScript status, state licensing, BBB record, FDA compliance, and overall legitimacy as a TRT and peptide telehealth provider.
An independent, evidence-based review of Marek Health's medical leadership, physician credentials, telehealth licensing, and how the platform compares to established clinical standards for TRT, peptides, and lab optimization.
An independent review of Midi Health's prescribing patterns, outcomes signals, regulatory standing, and patient complaints for women seeking perimenopause and menopause care.
Midi Health serves perimenopause and menopause patients well in many cases, but certain clinical and logistical profiles are a poor fit. Learn who should reconsider before enrolling.
An independent clinical review of Mochi Health's GLP-1 telehealth service. Learn which patient profiles should avoid Mochi Health, what the complaints reveal, and how to decide if it is a legitimate option for you.
An independent review of Momentous supplement complaints, BBB records, FDA databases, and third-party testing results to help you decide if the brand is legitimate.
An independent review of Momentous supplement legitimacy, LegitScript accreditation status, BBB rating, FDA compliance, third-party testing claims, and consumer complaints, with primary-source citations throughout.
An evidence-based, independent review of Momentous supplements, examining available outcomes data, regulatory standing, third-party testing claims, and what the absence of prescribing data means for clinical decision-making.
An independent, critically sourced review of Momentous supplement pricing history, trajectory, legitimacy, and complaint record. Covers NSF certification, third-party testing, BBB status, and price-per-serving benchmarks.
A critical, evidence-based review of Momentous performance supplements covering specific patient profiles who should avoid these products, ingredient safety data, and what independent sources say about the brand.
A breakdown of which patients should not use Musely, covering contraindications, safety signals, regulatory background, and complaint patterns, with primary-source citations throughout.
An independent review of Noom's Better Business Bureau rating, FTC complaints, state attorney-general actions, and GLP-1 program oversight, with primary-source citations and a clear framework for evaluating whether Noom is legitimate.
An independent review of Nurx's LegitScript certification, state pharmacy board standing, BBB rating, prescriber licensing, and complaint history. prepared by the HealthRX.com Editorial Team.
An independent, clinically grounded review of which patients should avoid Nurx for birth control, HRT, and skin care, with specific contraindications, complaint patterns, and safer alternatives.
An independent review of Nutrisense's LegitScript status, BBB rating, FDA regulatory standing, and dietitian accreditation. Includes real complaint data and a clinical framework for evaluating CGM coaching services.
An independent clinical review of Nutrisense's CGM-coaching subscription model, examining prescribing data signals, user outcomes, regulatory standing, and complaints. prepared by the HealthRX.com Editorial Team.
An independent review of Olipop's LegitScript status, FDA regulatory standing, BBB complaints, ingredient safety, and gut-health claims. Everything a consumer needs before buying.
A detailed, evidence-grounded look at Olipop's price per can over time, its D2C vs. Retail cost gap, ingredient legitimacy, and what the FDA and FTC records say about its health claims.
Olipop markets itself as a gut-healthy soda alternative, but certain patient profiles, IBS, FODMAP sensitivity, kidney disease, and others, may experience real harms. Here is what the clinical evidence says.
An independent review of Orderly Meds' LegitScript status, state pharmacy board standing, FDA compliance, BBB record, and compounding practices for GLP-1, peptides, and HRT.
A critical, evidence-based review of Orderly Meds for GLP-1, peptides, and HRT. Learn which patient profiles should avoid this cash-pay compounding service, what the FDA says about compounded semaglutide, and how to evaluate telehealth pharmacies safely.
An independent, data-driven review of Pandia Health's prescribing patterns, outcomes signals, complaint history, and legitimacy for birth control and menopause telehealth.
A critical, evidence-based look at which patients should avoid Pandia Health for birth control and menopause care, plus who the platform genuinely serves well. Written by the HealthRX.com medical team.
A data-driven, critical look at how Persona Nutrition's subscription pricing has changed over time, what complaints reveal about value, and what to watch before you subscribe.
An independent, clinically reviewed guide to the patient profiles that should avoid Persona personalized supplements, including drug interactions, safety concerns, and what the evidence actually shows.
An independent review of PlushCare's GLP-1 prescribing patterns, patient outcomes signals, complaint data, and regulatory standing, with citations to FDA, BBB, and clinical literature.
An independent clinical review of PlushCare's telehealth model, identifying the specific patient profiles for whom PlushCare is a poor fit, plus an honest look at complaints, legitimacy, and when it works well.
An independent review of Prime Mind's LegitScript certification status, state licensing, FDA compliance, BBB standing, and complaint history for ADHD and cognition telehealth.
An independent review of Ro's Better Business Bureau ratings, FDA warning letters, state-board actions, and verified consumer-complaint patterns across GLP-1, ED, hair, and mental-health services.
An independent review of Ro's LegitScript certification, pharmacy accreditation, state board standing, FDA compliance record, BBB ratings, and patient complaint history. Verified primary-source citations throughout.
An independent review of Seed Health's Better Business Bureau rating, consumer complaint patterns, FDA regulatory standing, and what buyers should know before subscribing.
An independent review of Seed Health's LegitScript status, BBB accreditation, FDA regulatory standing, and consumer complaints. Find out what the evidence actually shows before you subscribe.
A detailed, evidence-based look at Seed Health's pricing history, subscription model changes, complaint patterns, and what the clinical data actually says about DS-01 Daily Synbiotic.
A clinical review of which patient profiles should avoid Seed DS-01 Daily Synbiotic, including immunocompromised individuals, SIBO patients, post-surgical cases, and more. Evidence-based guidance with primary source citations.
An independent review of Sequence (now WeightWatchers Clinic) medical leadership, physician credentials, prescribing practices, and regulatory standing for GLP-1 telehealth care.
An independent, evidence-based review of Sequence (now WeightWatchers Clinic) GLP-1 prescribing practices, outcomes data, complaint patterns, and what prospective patients should ask before enrolling.
An evidence-based, independent analysis of Shapiro MD's prescribing practices, ingredient data, reported outcomes, BBB complaints, and regulatory standing for hair loss treatment.
An independent review of Signos complaint trends on the BBB, Reddit, the App Store, and FDA device databases. Includes CGM accuracy data, subscription-cancellation issues, and how Signos compares to clinical CGM standards.
An independent review of Signos's LegitScript status, BBB rating, FDA device classification, complaint history, and clinical evidence for CGM-guided weight loss.
An independent, evidence-based review of Signos CGM weight-loss platform: prescribing signals, clinical outcomes data, complaints, and what to know before subscribing.